Epidemiology and Aetiological Factors
Spina bifida refers to a wide range of neural tube defects (NTDs) affecting the spine and spinal cord. These defects result from the maldevelopment of the neuropore and the adjacent mesodermal and ectodermal structures during embryogenesis. Spina bifida can be classified as either open or closed type according to the presence or absence of exposed neural tissue. These are called spina bifida aperta and spina bifida occulta, respectively. Spina bifida aperta is caused by the failure of primary neurulation resulting in exposed neural tissue or meninges with or without cerebrospinal fluid leakage. It includes two main types: myelomeningocele and meningocele. Myelomeningocele is the severest form in which the spinal cord and the meninges protrude from an opening in the spine. Meningocele is a less severe form in which only the meninges and non-functional nerves protrude into a sac.
KeywordsSpina Bifida Neural Tube Defect Folic Acid Supplementation Folic Acid Intake Aetiological Factor
Unable to display preview. Download preview PDF.
- 4.Bower C, Raymond M, Lumley J et al (1993) Trends in neural tube defects 1980–1989. Med J Aus 158:152–154Google Scholar
- 5.Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980–1986. EUROCAT Working Group (1991) J Epidemiol Comm Health 45:52–58Google Scholar
- 6.Prevalence of neural tube defectsin 16 regions of Europe, 1980–1983. The EUROCAT Working Group (1987) Int J Epidemiol 16:246–251Google Scholar
- 11.Rosano A, Smithells D, Cacciani L et al (1999) Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Comm Health 53:630–635Google Scholar
- 13.Elwood JM, Little J, Elwood JH (1992) Epidemiology and control of neural tube defects. Oxford University PressGoogle Scholar
- 17.Chatkupt S, Chatkupt S, Johnson WG (1993) Waardenburg syndrome and myelomeningocele in a family. J Med Gen 30:83–84Google Scholar
- 18.Hol FA, Geurds MP, Chatkupt S et al (1996) PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. J Med Gen 33:655–660Google Scholar
- 38.Spina bifidaand anencephaly before and after folic acid mandate—United States, 1995–1996 and 1999–2000 (2004) MMWR 53:362–365Google Scholar
- 43.Taylor MJ, Carney SM, Goodwin GM et al (2004) Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol (Oxford, England) 18:251–256Google Scholar
- 45.FSANZ: FoodStandards Australia and New Zealand Report 23 May 2007. http://www.foodstandards.gov.au/_srcfiles/P295%20Folate%20Fortification%20FFR %20+%20Attach%201%20FINAL.pdf.